Les métastases pulmonaires de sarcomes utérins peuvent bénéficier d'une hormonothérapie !

Care should be taken in the institution of HRT in a woman with a history of low grade ESS. Hormonal treatment with aromatase inhibitors may be considered in cases where ER and PR are expressed by the primary tumour and metastases, with possible benefits even in metastatic disease.